Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism
In this study, a diabetic kidney disease model was established by placing the test rats on a high-sugar/high-fat diet combined with streptozotocin induction. Histopathological examination (H&E, Masson, and PASM stain) showed pathological changes in the diabetic rat kidneys, in addition to fibrot...
Saved in:
Main Authors: | Yan Wang, Yanlei Sun, Fengli Shao, Bo Zhang, Zhen Wang, Xinpeng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2021/7618166 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Iron and ferroptosis in kidney disease: molecular and metabolic mechanisms
by: Wenjie Wang, et al.
Published: (2025-02-01) -
Separation, Purification, Structural Characterization and in Vitro Antioxidant Activity of Low Molecular Mass Fucoidans
by: YU Fan, GUO Yingying, LI Na, DAI Xinyue, ZHU Wenjia, YAO Lin, JIANG Yanhua, WANG Lianzhu
Published: (2025-01-01) -
Natural products targeting ubiquitination to combat kidney fibrosis
by: Lianhua Li, et al.
Published: (2025-01-01) -
Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis
by: Jing Sun, et al.
Published: (2017-01-01) -
Baicalin: a potential therapeutic agent for acute kidney injury and renal fibrosis
by: Xiaoming Li, et al.
Published: (2025-01-01)